IL-12 gene therapy (Methodist Hospital)

N/A

Report date: 2026/01/24 20:00:19

Base Information

Drug NameIL-12 gene therapy (Methodist Hospital)
Drug Alias NameInterleukin 12 gene therapy (Methodist Hospital)IL-12基因疗法-卫理公会医院
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionInterleukin-12 stimulants
TargetsInterleukin-12
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThe Methodist Hospital Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Methodist Hospital Research Institute
Active IndicationsN/A
Inactive IndicationsTriple Negative Breast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A